Advertisement

Archive

Thrombosis and Haemostasis

ISSN: 0340-6245

Archive

2017

 Issue 10 2017 (pp 1833-2007)
Issue 9 2017 (pp 1661-1831)
Issue 8 2017 (pp. 1455-1659)
Issue 7 2017 (pp. 1217-1454)
Issue 6 2017 (pp. 1007-1216)
Issue 5 2017 (pp. 822-1005)
Issue 4 2017 (pp. 647-821)
Issue 3 2017 (pp. 429-646)
Issue 2 2017 (pp. 207-428)
Issue 1 2017 (pp. 1-206)

2016

 116/6 (Dec) pp. 1003–1181
116/5 (Nov) pp. 777-1002

Theme Issue
Heparin-induced thrombocytopenia in 2017 and beyond
116/4 (Oct) pp. 587-776

Theme Issue
GTH 2016 – State of the Art
Supplement 2 2016

Addressing the Clinical Questions …
From Research to Real World
Global Science Forum 2015
Guest Editor: A. John Camm (UK)
116/3 (Sep) pp. 403–585
Supplement 1 2016

5th International Coagulation Meeting 2015
The evolving role and future relevance of plasma-derived therapies in the management of bleeding disorders
116/2 (Aug) pp. 205–402
116/1 (July) pp. 1-203
115/6 (June) pp. 1081–1248
115/5 (May) pp. 871–1079
115/4 (Apr) pp. 685–870
115/3 (Mar) pp. 465–684

Theme Issue
Biomechanics in vascular biology and cardiovascular disease
115/2 (Feb) pp. 233–463
115/1 (Jan) pp. 1–232

2015

 114/6 (Dec) pp. 1093–1323
114/5 (Nov) pp. 869–1091

Theme Issue
Genetic aspects of thrombotic disease
114/4 (Oct) pp. 657-867
114/3 (Sep) pp. 445–656

Theme Issue
Platelets, inflammation and anti-inflammatory drugs in ACS and CAD
114/2 (Aug) pp. 211-444
114/1 (July) pp. 1-210
113/6 (June) pp. 1159–1382

Theme Issue
Venous thromboembolism
113/5 (May) pp. 911–1157
113/4 (Apr) pp. 671–909
113/3 (Mar) pp. 437–670

Theme Issue
Frontiers in Cardiovascular Research
113/2 (Feb) pp. 221–435
113/1 (Jan) pp. 1–220

2014

 112/6 (Dec) pp. 1077–1327
112/5 (Nov) pp. 843–1075

Theme Issue
Coagulation proteases and cardiovascular disease
112/4 (Oct) pp. 627-842

Theme Issue
Infections and the role of plasma proteins and platelets
112/3 (Sep) pp. 427–626
112/2 (Aug) pp. 223-426
112/1 (July) pp. 1-221
111/6 (June) pp. 1007–1199
111/5(May) pp. 781-1006

Theme Issue
New oral anticoagulants for stroke prevention in atrial fibrillation
111/4 (Apr) pp. 565–779

Theme Issue
GTH – State of the Art
111/3 (Mar) pp. 381-564
111/2 (Feb) pp. 189–380
111/1 (Jan) pp. 1–189

2013

 110/6 (Dec) pp. 1087-1307
110/5 (Nov) pp. 857-1085

Theme Issue
Platelets: basic mechanisms and translational implications
110/4 (Oct) pp. 623-856

Theme Issue
Obesity and vascular disease
110/3 (Sep) pp. 393–622

Theme Issue
Kallikreins: Pathobiology and association to disease
110/2 (Aug) pp. 205-392
110/1 (July) pp. 1-204
Index

109/Index
109/6 (June) pp. 977–1185
109/5(May) pp. 769-975

Theme Issue
High on-treatment platelet reactivity
109/4 (Apr) pp. 569-768
109/3 (Mar) pp. 361-567

Theme Issue
Highlights from the IVBM 2012
109/2 (Feb) pp. 175-360
109/1 (Jan) pp. 1–173

2012

 Index

108/Index
108/6 (Dec) pp. 1009–1248

Theme Issue
Scoring in thrombotic cardiovascular disease
108/5 (Nov) pp. 801-1007

Theme Issue
European Vascular Biology Meeting 2011 (Part 2)
108/4 (Oct) pp. 589-800

Theme Issue
MicroRNAs in vascular biology: Circulating miRNAs
108/3 (Sep) pp. 405-588

Theme Issue
European Vascular Biology Meeting 2011 (Part 1)
108/2 (Aug) pp. 201-403
108/1 (July) pp. 1-200
Index

107/Index
107/6 (June) pp. 1009–1194
107/5(May) pp. 803-1007
107/4 (Apr) pp. 601-801

Theme Issue
MicroRNAs in vascular biology:
Metabolism and atherosclerosis
107/3 (Mar) pp. 397-599
107/2 (Feb) pp. 201-395
107/1 (Jan) pp. 1–199

2011

 Index

106/Index
106/6 (Dec) pp. 993-1234
106/5 (Nov) pp. 753-992

Theme Issue
Immunology of atherosclerosis
106/4 (Oct) pp. 567–752
106/3 (Sep) pp. 389–565
106/2 (Aug) pp. 185-387

Theme Issue
Platelet function testing: From bench to bedside
106/1 (July) pp. 1-184
Index

105/Index
105/6 (June) pp. 933–1123
105/Supplement 1

Contemporary issues in atherothrombosis
105/5(May) pp. 743-932

Theme Issue
Intravital imaging of inflammation
105/4 (Apr) pp. 571-741
105/3 (Mar) pp. 387-570
105/2 (Feb) pp. 207-386
105/1 (Jan) pp. 1–205

2010

 Index

104/Index
104/6 (Dec) pp. 1083-1289
104/5 (Nov) pp. 863-1082

Theme Issue Ratnoff Symposium 2009
104/4 (Oct) pp. 655–861
104/3 (Sep) pp. 421–653

Theme Issue: Highlights from EMVBM 2009
104/2 (Aug) pp. 191– 419
104/1 (July) pp. 1-190

Stem cells in cardiovascular biology and medicine
Index

103/Index
103/6 (June) pp. 1109–1281
103/5 (May) pp. 875–1108

Hot topics in Cardiovascular Cell and Pharmacotherapy (Part 2)
103/4 (Apr) pp. 683–873
103/3 (Mar) pp. 481–681

Hot topics in Cardiovascular Cell and Pharmacotherapy (Part I)
103/2 (Feb) pp. 251–479
103/1 (Jan) pp. 1–249

2009

 Index

102/Index
102/6 (Dec) pp. 1007–1291

Infections of the Endothelium
102/5 (Nov) pp. 799-1006

Heparin and its derivatives – Present and future
102/4 (Oct) pp. 611-798
102/3 (Sep) pp. 421-610
102/2 (Aug) pp. 183-420
102/1 (July) pp. 1-183
Index

101/Index
101/6 (June) pp. 796-1180

Recent advances in vascular biology: Selected highlights from IVBM 2008
101/5 (May) pp. 795-990
101/4 (Apr) pp. 605-794

First international symposium of the Excellence Cluster "Cardio-Pulmonary System" (ECCPS)
101/3 (Mar) pp. 413-603
101/2 (Feb) pp. 217-412

Thrombotic microangiopathies: New developments and translation into medicine
101/1 (Jan) pp. 1-216

2008

 Index

100/Index
100/6 (Dec) pp. 955-1217
100/5 (Nov) pp. 727-954
100/4 (Oct) pp. 517-726

New vitamin K-dependent proteins
100/3 (Sep) pp. 365-516
100/2 (Aug) pp. 173-364
100/1 (July) pp. 1-171
Index

99/Index
99/6 (June) pp. 985-1136
99/5 (May) pp. 799-983

Current use of biologicals in thrombosis and haemostasis
99/4 (Apr) pp. 647-797
99/3 (Mar) pp. 457-645

From Molecules to Medicine: New Horizons in Vascular Biology and Thrombosis (Part II)
99/2 (Feb) pp. 249-455

From Molecules to Medicine: New Horizons in Vascular Biology and Thrombosis (Part I)
99/1 (Jan) pp. 1-248
  1-10 11-20
Next page